Breaking The Barrier: Leveraging Longer Treatment Intervals to Improve Adherence With Anti-VEGF Therapy for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

PROGRAM CHAIR

Jason Hsu, MD
Professor of Ophthalmology
Sidney Kimmel Medical College, Thomas Jefferson University
Co-Director of Retina Research
The Retina Service of Wills Eye Hospital
Wills Eye Physicians – Mid Atlantic Retina
Philadelphia, PA

PROGRAM OVERVIEW

This educational enduring activity provides ophthalmology clinicians with the opportunity to recognize the burden of anti-VEGF therapy on patients, its impact on adherence, and integrate new research about therapeutic strategies in nAMD and DME. The program aims to provide participants with strategies to reduce treatment burden for patients through longer treatment intervals in order to optimize outcomes. Recent clinical trial data is analyzed on the differences between conventional and next generation anti-VEGF agents, and participants will learn more about dosing strategies through an augmented reality animation.

TARGET AUDIENCE

This activity is designed to meet the educational needs of retina specialists, ophthalmologists, and other healthcare providers who manage patients with retinal vascular disease.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Examine how treatment burden can become a barrier to adherence with anti-VEGF modalities in the management of nAMD and DME
  • Recognize treatment interval differences between conventional and next-generation anti-VEGF agents for nAMD and DME
  • Identify strategies for achieving longer treatment intervals to reduce treatment burden, with the aim to impact treatment adherence in nAMD and DME

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

Faculty Member Disclosures
Jason Hsu, MD Received Consulting Fees for: Astellas Pharma, Gyroscope Therapeutics.
Grant Support for: Astellas Pharma, Genentech/Roche, Regeneron Pharmaceuticals, Stealth BioTherapeutics, Aldeyra Therapeutics.

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
  • Nicolas Applyrs, DO, has nothing to disclose.
  • Sarah Milano, RN, MSN, has nothing to disclose.
  • Nicole Longo, MD, Medical Director for Med Learning Group, has nothing to disclose.
  • Sharon Windsor Harker, Medical Director for Med Learning Group has nothing to disclose
  • Ana Maria Albino, Senior Program Manager for Med Learning Group, has nothing to disclose.
  • Jessica Feygin-Samuels, Associate Program Manager for Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
  • Daniel Dasilva, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: June 14, 2024
EXPIRATION DATE: June 14, 2025

Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top